Key result
Exercise during HeartMate 3 LVAD support relied primarily on native cardiac output rather than LVAD flow augmentation, resulting in blunted peak TCO.
Why the study?
Continuous flow left ventricular assist devices (cf-LVADs) improve survival and quality of life, but the central hemodynamic and peripheral reasons why maximal exercise capacity remains significantly diminished are incompletely understood.
Observational (n=9)
Maximal exercise capacity in HeartMate 3 LVAD patients is limited by blunted total cardiac output and rapid elevations in filling pressures, as augmentation of flow during exercise depends primarily on native heart function rather than the LVAD itself.
Answers are grounded in this paper and cite their sources.
Impaired cardiac reserve and pulmonary vasoreactivity may limit exercise in HM3 recipients; leaves open whether targeted interventions can improve capacity.
Background . Continuous flow left ventricular assist devices (cf-LVADs) improve survival and quality of life; however, maximal exercise capacity remains significantly diminished for reasons that are incompletely understood. Aims . To study central hemodynamic and peripheral determinants of maximal exercise during cf-LVAD support, utilizing invasive hemodynamics and cardiovascular modeling (Harvi). Methods . Ambulatory HeartMate 3™ (HM3) LVAD subjects underwent a familiarization upright ramp bicycle cardiopulmonary exercise test (CPET), followed by a second CPET with invasive hemodynamic measurements 4-12 days later. Arterial lactate, regional tissue oxygenation (rSO 2 ) and frailty were assessed. Pressure/flow relationships were generated for pulmonary arterial pressure (PAP) and pulmonary capillary wedge pressure (PCWP). Native cardiac output (NCO) was calculated by subtracting LVAD flow from total cardiac output (TCO). Patient-specific "digital twins" were generated using cardiovascular modeling (Harvi) to estimate right and left ventricular end-systolic elastance (RV and LV Ees) and estimated stressed blood volume (eSBV). Results . Nine subjects (60±12 years, 78% male) performed maximal exercise (respiratory exchange ratio [RER] ≥1.10). Peak oxygen consumption (pVO 2 ) was diminished (13.1±3.4mL/kg/min) with VO 2 at anaerobic threshold (AT) only 29.7±6.2% predicted. There was mild chronotropic incompetence. No subjects were frail. At peak exercise, we saw robust oxygen extraction (AVO 2 13.9±1.9 ml O2/100mL), rise in lactate and fall in rSO2. Peak TCO was blunted (8.0±2.4 L/min), driven primarily by NCO rather than LVAD flow (ΔNCO 3.0±2.1 vs ΔLVAD 1.1±0.4 L/min, p<0.05). Peak exercise was associated with significant increases in central venous pressure (CVP) and PCWP, marked reductions in systemic vascular resistance (SVR), and no significant change in total pulmonary resistance (TPR). Pressure/flow slopes showed abnormally steep rise in both mean PAP and PCWP in most subjects. There were significant increases in eSBV and RV Ees, with no significant change in LV Ees. Increases in eSBV were strongly associated with elevations in CVP and PCWP. Conclusion . Exercise after cf-LVAD is dependent on native heart function rather than augmentation in LVAD flow. Increases in eSBV and RV contractile reserve, together with limited LV contractile reserve and minimal LVAD flow augmentation (∼1L/min), result in elevated filling pressures and blunted TCO. Diminished TCO, rapid elevation in PCWP and early AT limit maximal exercise. Future studies should evaluate whether optimization of neurohormonal therapy can enhance native cardiac reserve, modulate eSBV, and improve exercise tolerance in LVAD patients.
No takes yet. Share an insight, caveat, or question.
Golombeck et al. (2026) conducted an observational in HeartMate 3 LVAD support (n=9). Maximal upright ramp bicycle cardiopulmonary exercise testing with invasive hemodynamic measurements and Harvi cardiovascular modeling was evaluated on Central hemodynamic and peripheral determinants of maximal exercise capacity (including peak VO2, total cardiac output, native cardiac output, and LVAD flow) (p=<0.05). Exercise during HeartMate 3 LVAD support relied primarily on native cardiac output rather than LVAD flow augmentation, resulting in blunted peak TCO.